资源描述：
《访谈型用药指导对2型糖尿病患者血糖相关指标的影响研究》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。
1、访谈型用药指导对2型糖尿病患者血糖相关指标的影响研究【摘耍】目的：探讨访谈型用药指导对2型糖尿病(T2DM)患者血糖相关指标的影响。方法：回顾性分析2013年1月-2014年12月在本院诊治200例T2DM患者的临床资料，采用随机数字表法将患者分为两组，每组各100例。对照组给予常规用药指导，观察组给予访谈型用药指导措施，比较两组患者的血糖情况。结果：干预前，两组患者的FBG、2hBG及HbAlc水平比较差异无统计学意义(P〉0.05)；干预1个月后，观察组指标分别为(5.82±0.42)mmol/L>(7.41±0.66)mmol/L、(5.38±0.32)%,对照组分别为(7.
2、85±0.72)mmol/L>(9.63土0.64)mmol/L、(7.21±0.56)%,两组的血糖指标均较干预前明显改善，观察组患者改善程度明显优于对照组，差异冇统计学意义(P0.05)；干预后两组的用药知识掌握率均较干预前明显改善，分别为96.0%与80.0%,观察组的改善情况明显高于对照组，两组比较差异有统计学意义(P〈0・05)。结论：访谈型用药指导措施能够显著改善患者的血糖情况，提高患者的合理用药知晓率。【关键词】2型糖尿病；访谈；用药指导；血糖波动；药剂【Abstract】Objective：Toinvestigatetheinterviewmedicationgui
3、defortype2diabetesmellitus(T2DM)indexinfluencingthebloodsugar.Method：Theclinicaldataofdiagnosisandtreatmentof200T2DMpatientswereretrospectiveonalyzedfromJanuary2013toDecember2014inourhospital,andrandomlydividedintotwogroupsaccordingthemethodofrandomnumbertable,100casesineachgroup・Thecontrolgro
4、upreceivedroutinemedicationguidance,theobservationgroupwasgiveninterviewmedicationguidaneemeasures,thebloodsugarlevelstatisticaloftwogroupswerecompared.Result：Beforetheintervention,thedifferenceoftwogroupshadnostatisticallysignificant(P>0.05)；1monthaftertheintervention,theobservationgroupindex
5、were(5.82+0.42)mmol/L,(7.41±0.66)mmol/Land(5.38±0.32)%,thecontrolgroupwere(7.85±0.72)mmol/L,(9.63±10.64)mmol/Land(7.21±0.56)%,bloodglucoseindexofthetwogroupswerecomparedwiththatbeforetheinterventionsignificantlyimproved,thepatientsinobservationgroupweresignificantlybetterthantheimproveddegreet
6、hecontrolgroup,thedifferenceswerestatisticallysignificant(P0.05)；interventionoftwogroupsaftermedicationknowledgeratethanbeforetheinterventionsignificantlyimproved,respectively96%and80%,theimprovmentthesituationoftheobservationgroupwassignificantlyhigherthanthatinthecontrolgroup,thedifferencewa
7、sstatisticallysignificant(P<0.05).Conclusion：Theinterviewmedicationguidancemeasurescansignificantlyimprovebloodsugarcontrolofpatients,improvetherationaluseofdrugsinpatientswithknownrate.［Keywords］Type2diabetesmellitus；Interview；Druginst
